Medisafe key facts
- Developer of a medication management platform designed to address significant causes of non-adherence to medication schedules.
- It has raised $51.5M across 1 recorded rounds; the latest was Later Stage VC (Series C) ($30.0M) in Feb 2021.
- Notable investors include Google for Startups, Qualcomm Ventures, Microsoft for Startups, Octopus Ventures, OurCrowd — 24 tracked in total.
- Status: Privately Held (backing).
Who backs Medisafe
24+- ·The complete investor list: 24 names
- ·Watch Medisafe: the Monday email on marks, rounds and moves
Medisafe funding rounds
1 roundsHow much has Medisafe raised?
Medisafe has raised $51.5 million in total; 1 of its rounds is on record. The largest on record was a $30 million Series C in Feb 2021.
Medisafe investors
24 investors are on record for Medisafe, including Google for Startups, Qualcomm Ventures, Microsoft for Startups and Octopus Ventures. By type, the record holds 5 venture capital firms and 1 private equity firm. The Series C in Feb 2021 drew 14 investors.
About Medisafe
Developer of a medication management platform designed to address significant causes of non-adherence to medication schedules. The company's platform facilitates patient-centric cloud-synced medication management addressing major causes of non-adherence and has features to send alerts to users and caretakers at medication time, enabling the medical community and patients to stay organized, informed, and on a budget.
- Industry
- Other Healthcare Technology Systems
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2012
- Employees
- 110
- Website
- medisafe.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Medisafe doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.